Kemptide (Synonyms: NSC 332190) |
| カタログ番号GC13640 |
ケンプチドは、cAMP 依存性プロテインキナーゼ (PKA) の特異的基質として機能する合成ヘプタペプチドです。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 65189-71-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Kemptide is a synthetic heptapeptide that acts as a substrate for cAMP-dependent protein kinase (PK) [1].
Cyclic AMP-dependent protein kinase is the sole intracellular acceptor for cyclic AMP in all cell types. Protein phosphorylation by different types of protein kinase (PK) activities comprises a form of protein modification that plays an important role in the regulation of numerous biological processes [1][2].
Kemptide is a novel synthetic heptapeptide phosphate acceptor that acts as a substrate for cAMP-dependent protein kinase. Kemptide had all the properties of a cytophilic substrate and could preserving cell membrane intactness when added to cultured cells. In the presence of extracellular ATP and cAMP, different types of intact cells catalyzed the phosphorylation of Kemptide with Km values of 3-4 μM. Kemptide phosphorylation was influenced by PKI, the inhibitory protein specific for cAMP-PK [1]. Kemptide was usually used as a substrate for detection of activities of soluble A-kinase isolated from guinea-pig lung parenchyma and from bovine tracheal smooth muscle [2][3].
References:
[1]. Kübler D, Pyerin W, Bill O, et al. Evidence for ecto-protein kinase activity that phosphorylates Kemptide in a cyclic AMP-dependent mode. J Biol Chem. 1989 Aug 25;264(24):14549-55.
[2]. Giembycz MA, Diamond J. Evaluation of kemptide, a synthetic serine-containing heptapeptide, as a phosphate acceptor for the estimation of cyclic AMP-dependent protein kinase activity in respiratory tissues. Biochem Pharmacol. 1990 Jan 15;39(2):271-83.
[3]. Langlands JM, Rodger IW. Determination of soluble cAMP-dependent protein kinase activity in guinea-pig tracheal smooth muscle. Preferential use of kemptide as a phosphorylating substrate. Biochem Pharmacol. 1990 Apr 15;39(8):1365-74.
|
Kinase experiment: |
PKA activity is measured in pools of 10 oocytes at various stages of maturation using the SignaTECT cAMP-Dependent Protein Kinase (PKA) Assay System. Measurements of basal PKA activity are performed in the absence of exogenous cAMP, whereas measurements of total (cAMP-stimulated) PKA activity are performed in reaction buffer containing 0.025 mM cAMP[2]. |
|
References: [1]. Kübler D, et al. Evidence for ecto-protein kinase activity that phosphorylates Kemptide in a cyclic AMP-dependent mode. J Biol Chem. 1989 Aug 25;264(24):14549-55. |
|
| Cas No. | 65189-71-1 | SDF | |
| 同義語 | NSC 332190 | ||
| Chemical Name | (5S,8S,11S,14S,17S,20S)-20-amino-14,17-bis(3-guanidinopropyl)-8-(hydroxymethyl)-5-isobutyl-11,22-dimethyl-4,7,10,13,16,19-hexaoxo-3,6,9,12,15,18-hexaazatricosan-1-oic acid | ||
| Canonical SMILES | OC(CNC([C@H](CC(C)C)NC([C@H](CO)NC([C@H](C)NC([C@@H](NC([C@@H](NC([C@@H](N)CC(C)C)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)=O)=O)=O)=O | ||
| Formula | C32H61N13O9 | M.Wt | 771.9 |
| 溶解度 | DMF: 30 mg/ml,DMSO: 25 mg/ml,PBS (pH 7.2): 10 mg/ml | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 1.2955 mL | 6.4775 mL | 12.955 mL |
| 5 mM | 0.2591 mL | 1.2955 mL | 2.591 mL |
| 10 mM | 0.1296 mL | 0.6478 mL | 1.2955 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >96.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 38 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *